Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9854257 | 1.00 | LMNA (0.41) | LMNA | |
| SCHEMBL5556024 | 1.00 | LMNA (0.41) | LMNA | |
| SCHEMBL9854413 | 1.00 | LMNA (0.41) | LMNA | |
| SCHEMBL9854339 | 1.00 | LMNA (0.41) | LMNA | |
| SCHEMBL2495980 | 0.97 | LMNA (0.36) | LMNA | |
| SCHEMBL9854322 | 0.88 | LMNA (0.32) | LMNA | |
| SCHEMBL29461640 | 0.88 | — | — | |
| SCHEMBL3480962 | 0.84 | LMNA (0.38) | LMNA | |
| SCHEMBL28070551 | 0.82 | LMNA (0.36) | LMNA | |
| SCHEMBL7643011 | 0.82 | LMNA (0.42) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739728-A1 | TUNABLE POLYISOBUTYLENE POLYURETHANE | Boston Scientific Scimed, Inc. (US) | 2026-05-13 | — | — | EP | claimed |
| WO-2025010284-A1 | TUNABLE POLYISOBUTYLENE POLYURETHANE | BOSTON SCIENTIFIC SCIMED INC. (US) | 2025-01-09 | — | — | WO | claimed |
| US-20250011541-A1 | TUNABLE POLYISOBUTYLENE POLYURETHANE | BOSTON SCIENTIFIC SCIMED, INC. | 2025-01-09 | — | — | US | claimed |
| EP-4739728-A1 | TUNABLE POLYISOBUTYLENE POLYURETHANE | Boston Scientific Scimed, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025010284-A1 | TUNABLE POLYISOBUTYLENE POLYURETHANE | BOSTON SCIENTIFIC SCIMED INC. (US) | 2025-01-09 | — | — | WO | disclosed |
| US-20250011541-A1 | TUNABLE POLYISOBUTYLENE POLYURETHANE | BOSTON SCIENTIFIC SCIMED, INC. | 2025-01-09 | — | — | US | disclosed |
| CN-111501409-A | Suspension for deacidifying paper | 齐鲁工业大学 | 2020-08-07 | — | — | CN | disclosed |
| US-7226578-B2 | Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis | SHERING AG (DE) | 2007-06-05 | — | — | US | disclosed |
| US-6916461-B2 | Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis | SCHERING AG (DE) | 2005-07-12 | — | — | US | disclosed |
| US-20050147563-A1 | Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2005-07-07 | — | — | US | disclosed |
| US-20030232012-A1 | Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis | SCHERING AG (DE) | 2003-12-18 | — | — | US | disclosed |
| US-6468502-B1 | PARAMAGNETIC MACROMOLECULES WITH HIGHER PROTON RELAXIVITY; LOWER DOSAGE AND INCREASED SIGNAL INTENSITY; DETECTING VASCULAR DISEASES; DIFFERENTIATING TISSUE BLOOD SUPPLY LEVELS; DISTINGUISHING MYOCARDIAL INFARCTION FROM ISCHEMIA | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-10-22 | — | — | US | disclosed |
| EP-0874645-B1 | PERFLUOROALKYL-CONTAINING METAL COMPLEXES AND THEIR USE IN NMR DIAGNOSTICS | SCHERING AG (DE) | 2002-04-03 | — | — | EP | disclosed |
| EP-0882010-B1 | PHARMACEUTICAL AGENTS CONTAINING PERFLUOROALKYL-CONTAINING METAL COMPLEXES AND THE USE THEREOF IN TUMOUR THERAPY AND INTERVENTIONAL RADIOLOGY | SCHERING AG (DE) | 2001-05-02 | — | — | EP | disclosed |
| US-6180113-B1 | USED IN TUMOR THERAPY AND INTERVENTIONAL RADIOLOGY | SCHERING AG (DE) | 2001-01-30 | — | — | US | disclosed |
| EP-0882010-A1 | PHARMACEUTICAL AGENTS CONTAINING PERFLUOROALKYL-CONTAINING METAL COMPLEXES AND THE USE THEREOF IN TUMOUR THERAPY AND INTERVENTIONAL RADIOLOGY | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-12-09 | — | — | EP | disclosed |
| WO-1997030969-A1 | PHARMACEUTICAL AGENTS CONTAINING PERFLUOROALKYL-CONTAINING METAL COMPLEXES AND THE USE THEREOF IN TUMOUR THERAPY AND INTERVENTIONAL RADIOLOGY | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-08-28 | — | — | WO | disclosed |
| EP-0252736-B1 | PROCESS FOR PREPARING FLUORINE-CONTAINING CARBOXYLIC ACID ESTER | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1991-07-24 | — | — | EP | disclosed |
| US-4855487-A | Process for preparing fluorine-containing carboxylic acid ester | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1989-08-08 | — | — | US | disclosed |
| EP-0252736-A2 | Process for preparing fluorine-containing carboxylic acid ester | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1988-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050147563-A1 | Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis | FABP1, FLOT1, AFF1 | LMNA 1611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.